Areas of Interest and Social Consideration of Antidepressants on English Tweets: A Natural Language Processing Classification Study.
antidepressants
artificial intelligence
depression
machine learning
pharmacoepidemiology
psychopharmacology
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
25 Jan 2022
25 Jan 2022
Historique:
received:
15
12
2021
revised:
11
01
2022
accepted:
18
01
2022
entrez:
25
2
2022
pubmed:
26
2
2022
medline:
26
2
2022
Statut:
epublish
Résumé
Antidepressants are the foundation of the treatment of major depressive disorders. Despite the scientific evidence, there is still a sustained debate and concern about the efficacy of antidepressants, with widely differing opinions among the population about their positive and negative effects, which may condition people's attitudes towards such treatments. Our aim is to investigate Twitter posts about antidepressants in order to have a better understanding of the social consideration of antidepressants. We gathered public tweets mentioning antidepressants written in English, published throughout a 22-month period, between 1 January 2019 and 31 October 2020. We analysed the content of each tweet, determining in the first place whether they included medical aspects or not. Those with medical content were classified into four categories: general aspects, such as quality of life or mood, sleep-related conditions, appetite/weight issues and aspects around somatic alterations. In non-medical tweets, we distinguished three categories: commercial nature (including all economic activity, drug promotion, education or outreach), help request/offer, and drug trivialization. In addition, users were arranged into three categories according to their nature: patients and relatives, caregivers, and interactions between Twitter users. Finally, we identified the most mentioned antidepressants, including the number of retweets and likes, which allowed us to measure the impact among Twitter users. The activity in Twitter concerning antidepressants is mainly focused on the effects these drugs may have on certain health-related areas, specifically sleep (20.87%) and appetite/weight (8.95%). Patients and relatives are the type of user that most frequently posts tweets with medical content (65.2%, specifically 80% when referencing sleep and 78.6% in the case of appetite/weight), whereas they are responsible for only 2.9% of tweets with non-medical content. Among tweets classified as non-medical in this study, the most common subject was drug trivialization (66.86%). Caregivers barely have any presence in conversations in Twitter about antidepressants (3.5%). However, their tweets rose more interest among other users, with a ratio 11.93 times higher than those posted by patients and their friends and family. Mirtazapine is the most mentioned antidepressant in Twitter (45.43%), with a significant difference with the rest, agomelatine (11.11%). This study shows that Twitter users that take antidepressants, or their friends and family, use social media to share medical information about antidepressants. However, other users that do not talk about antidepressants from a personal or close experience, frequently do so in a stigmatizing manner, by trivializing them. Our study also brings to light the scarce presence of caregivers in Twitter.
Sections du résumé
BACKGROUND
BACKGROUND
Antidepressants are the foundation of the treatment of major depressive disorders. Despite the scientific evidence, there is still a sustained debate and concern about the efficacy of antidepressants, with widely differing opinions among the population about their positive and negative effects, which may condition people's attitudes towards such treatments. Our aim is to investigate Twitter posts about antidepressants in order to have a better understanding of the social consideration of antidepressants.
METHODS
METHODS
We gathered public tweets mentioning antidepressants written in English, published throughout a 22-month period, between 1 January 2019 and 31 October 2020. We analysed the content of each tweet, determining in the first place whether they included medical aspects or not. Those with medical content were classified into four categories: general aspects, such as quality of life or mood, sleep-related conditions, appetite/weight issues and aspects around somatic alterations. In non-medical tweets, we distinguished three categories: commercial nature (including all economic activity, drug promotion, education or outreach), help request/offer, and drug trivialization. In addition, users were arranged into three categories according to their nature: patients and relatives, caregivers, and interactions between Twitter users. Finally, we identified the most mentioned antidepressants, including the number of retweets and likes, which allowed us to measure the impact among Twitter users.
RESULTS
RESULTS
The activity in Twitter concerning antidepressants is mainly focused on the effects these drugs may have on certain health-related areas, specifically sleep (20.87%) and appetite/weight (8.95%). Patients and relatives are the type of user that most frequently posts tweets with medical content (65.2%, specifically 80% when referencing sleep and 78.6% in the case of appetite/weight), whereas they are responsible for only 2.9% of tweets with non-medical content. Among tweets classified as non-medical in this study, the most common subject was drug trivialization (66.86%). Caregivers barely have any presence in conversations in Twitter about antidepressants (3.5%). However, their tweets rose more interest among other users, with a ratio 11.93 times higher than those posted by patients and their friends and family. Mirtazapine is the most mentioned antidepressant in Twitter (45.43%), with a significant difference with the rest, agomelatine (11.11%).
CONCLUSIONS
CONCLUSIONS
This study shows that Twitter users that take antidepressants, or their friends and family, use social media to share medical information about antidepressants. However, other users that do not talk about antidepressants from a personal or close experience, frequently do so in a stigmatizing manner, by trivializing them. Our study also brings to light the scarce presence of caregivers in Twitter.
Identifiants
pubmed: 35207644
pii: jpm12020155
doi: 10.3390/jpm12020155
pmc: PMC8879287
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Instituto de Salud Carlos III
ID : PI18/01726
Organisme : Comunidad de Madrid
ID : B2017/BMD-3804
Références
JAMA. 2010 Jan 6;303(1):47-53
pubmed: 20051569
Annu Rev Clin Psychol. 2013;9:355-77
pubmed: 23297787
J Med Internet Res. 2018 May 28;20(5):e205
pubmed: 29807880
BMC Psychiatry. 2021 Feb 15;21(1):94
pubmed: 33588795
Soc Psychiatry Psychiatr Epidemiol. 2019 Jan;54(1):51-58
pubmed: 30069754
Epidemiol Psichiatr Soc. 2009 Jan-Mar;18(1):23-33
pubmed: 19378696
BMJ. 2003 May 31;326(7400):1167-70
pubmed: 12775614
J Med Internet Res. 2017 Apr 05;19(4):e107
pubmed: 28381392
Hum Psychopharmacol. 2005 Dec;20(8):533-59
pubmed: 16229049
Digit Health. 2019 May 01;5:2055207619844865
pubmed: 31069103
J Med Internet Res. 2019 May 28;21(5):e14110
pubmed: 31140438
Cochrane Database Syst Rev. 2011 Dec 07;(12):CD006528
pubmed: 22161405
Br J Clin Pharmacol. 2017 Feb;83(2):227-246
pubmed: 27558545
PeerJ. 2014 Oct 28;2:e647
pubmed: 25374786
J Med Internet Res. 2021 Oct 26;23(10):e24336
pubmed: 34698653
J Ment Health. 2020 Apr;29(2):191-199
pubmed: 31694433
Schizophr Res. 2015 Jul;165(2-3):111-5
pubmed: 25937459
Prim Care. 2007 Sep;34(3):505-19, vi
pubmed: 17868757
JAMA Netw Open. 2020 Jun 1;3(6):e208953
pubmed: 32584408
Pain Manag Nurs. 2012 Mar;13(1):2-10
pubmed: 22341135
J Med Internet Res. 2014 Oct 15;16(10):e237
pubmed: 25591063
Int Rev Psychiatry. 2015 Apr;27(2):83-4
pubmed: 25828741
JAMA. 2003 Jun 18;289(23):3135-44
pubmed: 12813119
Acta Psychiatr Scand. 2003 Oct;108(4):304-9
pubmed: 12956832
Can Fam Physician. 2014 May;60(5):407-8
pubmed: 24828994
Ann Clin Psychiatry. 2010 Feb;22(1):43-55
pubmed: 20196982
BMC Psychiatry. 2015 Feb 19;15:29
pubmed: 25881089
NPJ Digit Med. 2018 Feb 12;1:
pubmed: 30740536
BJPsych Bull. 2019 Aug;43(4):158-166
pubmed: 30784393
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
Lancet. 2018 Apr 7;391(10128):1357-1366
pubmed: 29477251
JMIR Ment Health. 2018 Dec 13;5(4):e11483
pubmed: 30545811
JMIR Diabetes. 2021 Jan 26;6(1):e24681
pubmed: 33496671
Patient Prefer Adherence. 2016 Jul 28;10:1401-7
pubmed: 27528803
BMJ. 2016 Jan 20;532:i267
pubmed: 26792370
Res Social Adm Pharm. 2018 Jul;14(7):638-644
pubmed: 28811152
Lancet. 2015 Aug 15;386(9994):628-30
pubmed: 26334141
J Biomed Inform. 2015 Apr;54:202-12
pubmed: 25720841
Am J Public Health. 2017 Jan;107(1):e1-e8
pubmed: 27854532
Chonnam Med J. 2018 May;54(2):101-112
pubmed: 29854675
Curr Pharm Des. 2012;18(36):5958-75
pubmed: 22681172
Front Psychol. 2017 Aug 11;8:1356
pubmed: 28848472
Drug Saf. 2019 Aug;42(8):921-930
pubmed: 30929141
J Clin Med. 2021 Jun 17;10(12):
pubmed: 34204353
Br J Psychiatry. 2015 Jun;206(6):443-4
pubmed: 26034176
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
Daru. 2021 Jun;29(1):217-221
pubmed: 33715138
Pharmacol Res Perspect. 2020 Oct;8(5):e00640
pubmed: 32813329
Philos Ethics Humanit Med. 2008 May 27;3:14
pubmed: 18505564
Aust N Z J Psychiatry. 2006 Jan;40(1):51-4
pubmed: 16403038
JMIR Ment Health. 2021 Mar 19;8(3):e26589
pubmed: 33739296
J Clin Psychopharmacol. 2002 Feb;22(1):40-5
pubmed: 11799341
Asian J Psychiatr. 2014 Dec;12:69-76
pubmed: 25440564
JMIR Ment Health. 2017 Oct 18;4(4):e43
pubmed: 29046270
Front Psychol. 2019 Nov 15;10:2596
pubmed: 31803123
J Affect Disord. 2002 Dec;72(3):227-36
pubmed: 12450639
BMJ. 2015 May 12;350:h2435
pubmed: 25985333
J Med Internet Res. 2020 Feb 24;22(2):e16466
pubmed: 32130160
Int J Environ Res Public Health. 2021 Aug 28;18(17):
pubmed: 34501681
J Med Internet Res. 2020 Jul 29;22(7):e13979
pubmed: 32723724
PLoS One. 2019 Jan 16;14(1):e0207506
pubmed: 30650072
Lancet. 2009 Feb 28;373(9665):746-58
pubmed: 19185342
Curr Psychiatry Rep. 2015 Dec;17(12):94
pubmed: 26463050
Qual Health Res. 2008 Mar;18(3):405-17
pubmed: 18235163
Asian J Psychiatr. 2014 Apr;8:38-42
pubmed: 24655624
BMJ. 2015 May 14;350:h2611
pubmed: 25978967